Yes, you’re in the right place! MelNet is now Skin Cancer NZ.

Uniting to
fight skin cancer
and save lives

We are a community of over 1,500 professionals dedicated to reducing the incidence and impact of skin cancer in New Zealand

Join us today Make a donation
100,000
Kiwis are diagnosed with skin cancer each year
90%
of skin cancers are preventable
1,500+
members working together to improve care

2026 New Zealand Skin Cancer Summit

18 - 20 June 2026   |   InterContinental Wellington

Register now

Leading the fight against
skin cancer

Skin Cancer NZ is the leading organisation for skin cancer professionals in New Zealand. 

We are working towards a future with fewer skin cancers, and where every person - no matter who they are or where they live - receives the best possible care.

By shaping strategy, defining best practice, supporting professionals and advocating for change, we are driving a nationwide effort to improve outcomes and strengthen how skin cancers are prevented, detected and treated across New Zealand. 

Learn more
A group of medical professionals

Join the Skin Cancer NZ Foundation Club

A unique opportunity to be part of Skin Cancer NZ’s journey from the beginning. With only 100 places available, a one-off contribution will secure your spot as a founding member and help build a strong foundation for long-term impact. 

Find out more

Become a member

Skin Cancer NZ brings together health professionals, health promoters, researchers, policy makers, and advocates who are committed to improving skin cancer prevention, early detection and care. 

Membership is free and takes less than a minute to complete. 

Join now

Latest news

More articles
NZ research
Recent research highlights increased skin cancer mortality risk for kidney transplant recipients in New Zealand

18 June 2026

Recent research from Australia and New Zealand found kidney transplant recipients are 11 times more likely to die from skin cancer than the general population. This reinforces the need for ongoing regular skin surveillance and timely access to treatment for transplant recipients.
Skin Cancer NZ
Remembering Professor Richard Scolyer AO

8 June 2026

It is with great sadness that we have learned of the passing of Professor Richard Scolyer, AO.
Research
Five-year study shows improved long-term outcomes for advanced melanoma patients

5 June 2026

A presentation at the recent 2026 ASCO Annual Meeting shared five-year results from a major international clinical trial comparing nivolumab alone with a combination of nivolumab and relatlimab in people with advanced melanoma. The findings show that the combination treatment continues to provide longer-lasting disease control and improved survival outcomes, with no new safety concerns identified during long-term follow-up.

With thanks to our Founding Members

Supporting a future with better skin cancer outcomes for all New Zealanders. 

https://www.dermlab.co.nz/
https://sciprofiles.com/profile/361309
https://www.davinciclinic.co.nz/
https://www.skincancercollege.org/
https://molecheck.co.nz/
https://skinaware.co.nz/
https://www.luminomadx.com/
https://www.espyskin.co.nz/

Already a member?

Log in to update your details and access member content. Contact us if you need help. 

Log in